カテゴリー： Grand View Research, 世界, 医療/バイオ

世界のmiRNAシーケンス・アッセイ市場2021-2028：製品・サービス別、技術別、ワークフロー別、用途別（がん、自己免疫疾患、統合失調症）、エンドユーザー別、地域別

【英語タイトル】miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service, By Technology, By Workflow, By Application (Cancer, Autoimmune Disease, Schizophrenia), By End-use, By Region, And Segment Forecasts, 2021 - 2028

Grand View Researchが出版した調査資料（GV21JL022）・商品コード：GV21JL022
・発行会社（調査会社）：Grand View Research
・発行日：2021年7月8日
・ページ数：136
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥773,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥903,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,163,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
グランドビューリサーチ社は、miRNAシーケンス・アッセイの世界市場規模が2028年までに597.8百万ドルに達すると予測しています。2021年から2028年まで年平均13.0％成長する見通しです。本市場調査レポートでは、miRNAシーケンス・アッセイの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品・サービス別（製品、サービス）分析、技術別（合成シーケンシング、オリゴヌクレオチドライゲーション・検出（SOLiD）シーケンシング、ナノポアシーケンシング、サンガーシーケンス、単一分子リアルタイム（SMRT）シーケンス）分析、ワークフロー別（ライブラリ調製、シーケンス、データ分析・保存）分析、用途別（がん、ポリグルタミン病、自己免疫疾患、統合失調症、その他）分析、地域別分析、競争状況などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・miRNAシーケンス・アッセイの世界市場規模：製品・サービス別（製品、サービス）
・miRNAシーケンス・アッセイの世界市場規模：技術別（合成シーケンシング、オリゴヌクレオチドライゲーション・検出（SOLiD）シーケンシング、ナノポアシーケンシング、サンガーシーケンス、単一分子リアルタイム（SMRT）シーケンス）
・miRNAシーケンス・アッセイの世界市場規模：ワークフロー別（ライブラリ調製、シーケンス、データ分析・保存）
・miRNAシーケンス・アッセイの世界市場規模：用途別（がん、ポリグルタミン病、自己免疫疾患、統合失調症、その他）
・miRNAシーケンス・アッセイの世界市場規模：地域別
・競争状況
❖ レポートの概要 ❖

miRNA Sequencing And Assay Market Growth & Trends

The global miRNA sequencing and assay market size is expected to reach USD 597.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.0% from 2021 to 2028. Prominent players, such as Illumina, PerkinElmer, Qiagen, and others offer advanced miRNA sequencing products for multiple clinical applications. Moreover, these companies have collaborated with research institutes to expand the application of miRNA sequencing and assay in research studies.

The market holds a significant growth potential owing to the increasing application of miRNA sequencing and assay in the healthcare industry. For instance, several research studies demonstrate that miRNAs can be used as efficient biomarkers in the diagnosis and prognosis of cancer (breast, ovarian, cervical, and others), cardiovascular diseases, sepsis, and nervous system disorders. Therefore, miRNA sequence analysis is increasingly employed to analyze gene regulation in clinical disorders.

As plasma from COVID-19 recovered patients is rich in antiviral miRNAs and antibodies, it has been employed to treat SARS-CoV-2 infected patients. This has led to an increase in research studies that focus on the sequence analysis of miRNAs (microRNA) from the patient as well as the virus.

miRNA Sequencing And Assay Market Report Highlights

• The product segment dominated the market and accounted for the largest revenue share in 2020. The commercial presence of multiple players that offer extensive kits, consumables, and instruments for specialized applications contribute to segment growth

• Small and mid-sized research entities face financial limitations to install sequencing equipment owing to their high cost. Therefore, these organizations approach service providers. This is expected to drive the services segment with the fastest CAGR over the forecast period

• Sequencing by synthesis holds a major share of the technology segment owing to its high sensitivity, fast turnaround time, and high throughput

• Additionally, this technology is playing important role in the detection of mutations in tumor tissue which helps to develop targeted and personalized therapies

• The sequencing workflow segment held the largest revenue share in 2020 and is expected to witness the fastest CAGR during the forecast period as it is the most important and crucial step of the workflow

• The cancer application segment generated the largest revenue share in 2020 owing to ongoing extensive research in cancer using miRNA as a biomarker to study diagnosis and prognosis of cancer and to develop novel therapies

• Furthermore, an increase in the number of cancer patients globally drives segment growth

• Research and academic institutions are one of the major revenue generators of the market as miRNA sequencing and assay techniques and associated products are being widely used in various research studies conducted by research and academic institutes

• In Asia Pacific, the market is anticipated to register a lucrative growth rate throughout the forecast owing to the presence of a huge target population, growing establishment of healthcare, and high unmet clinical needs

❖ レポートの目次 ❖

Table of Content

Chapter 1 Methodology and Scope
1.1 Research Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.3.1 List of secondary data sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Region-wise market: Base estimates
1.6 Objectives
1.6.1 Objective 1:
1.6.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Industry Pyramid Analysis
3.1.1 Parent & ANCILLARY Market Analysis
3.2 Market Segmentation & Scope
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Advantages of miRNA Sequencing
3.3.1.2 MiRNAs as critical regulators of health and disease
3.3.1.3 Rise in prevalence of cancer and autoimmune disorders
3.3.1.4 Rise in adoption of RNA sequencing protocols in biotechnology research
3.3.2 Market restraint analysis
3.3.2.1 Limitations associated with Bioinformatic Analysis of MicroRNA Sequencing Data
3.3.3 Market opportunity analysis
3.3.3.1 Efforts taken to optimize miRNA-seq data processing
3.3.4 Market challenge analysis
3.3.4.1 Challenges associated with the validation and prediction of miRNA targetome
3.4 Penetration & Growth Prospect Mapping for Technology, 2020
3.5 COVID-19 Impact Analysis on Market
3.6 BUSINESS ENVIRONMENT ANALYSIS
3.6.1 MiRNA sequencing and assay Market – SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6.2 Porter’s Five Forces Analysis
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Product developments
3.7.2 Merger & acquisition
3.7.3 Agreement
3.7.4 Collaboration & partnership
Chapter 4 Product & Service Business Analysis
4.1 miRNA sequencing and assay market: Product & Services Movement Analysis, 2020 & 2028
4.2 Products
4.2.1 MiRNA Sequencing and Assay Products Market, 2017 – 2028 (USD Million)
4.2.2 Library Preparation Kits
4.2.2.1 Library Preparation Kits market, 2017 – 2028 (USD Million)
4.2.3 Sequencing Consumables
4.2.3.1 Sequencing Consumables market, 2017 – 2028 (USD Million)
4.2.4 Instruments
4.2.4.1 Instruments market, 2017 – 2028 (USD Million)
4.3 Services
4.3.1 MiRNA Sequencing and Assay Services Market, 2017 – 2028 (USD Million)
Chapter 5 Technology Business Analysis
5.1 miRNA sequencing and assay market: Technology Movement Analysis, 2020 & 2028
5.2 Sequencing by Synthesis
5.2.1 Sequencing By Synthesis Market, 2017 – 2028 (USD Million)
5.3 Sequencing by Oligonucleotide Ligation and Detection (SOLiD)
5.3.1 Sequencing By Oligonucleotide Ligation and Detection (SOLiD) Market, 2017 – 2028 (USD Million)
5.4 Nanopore Sequencing
5.4.1 Nanopore Sequencing Market, 2017 – 2028 (USD Million)
5.5 Sanger Sequencing
5.5.1 Sanger Sequencing Market, 2017 – 2028 (USD Million)
5.6 Single Molecule Real-time (SMRT) Sequencing
5.6.1 Single Molecule Real-time (SMRT) Sequencing Market, 2017 – 2028 (USD Million)
Chapter 6 Workflow Business Analysis
6.1 miRNA Sequencing and Assay Market: Workflow Movement Analysis, 2020 & 2028
6.2 Library Preparation
6.2.1 Library Preparation Workflow Market, 2017 – 2028 (USD Million)
6.3 Sequencing
6.3.1 Sequencing Workflow Market, 2017 – 2028 (USD Million)
6.4 Data Analysis & Storage
6.4.1 Data Analysis & Storage Workflow Market, 2017 – 2028 (USD Million)
Chapter 7 Application Business Analysis
7.1 miRNA Sequencing And Assay Market: Applications Movement Analysis, 2020 & 2028
7.2 Cancer
7.2.1 Cancer Market, 2017 – 2028 (USD Million)
7.3 Polyglutamine Diseases
7.3.1 Polyglutamine Diseases Market, 2017 – 2028 (USD Million)
7.4 Autoimmune Disease
7.4.1 Autoimmune Disease Market, 2017 – 2028 (USD Million)
7.5 Schizophrenia
7.5.1 Schizophrenia Market, 2017 – 2028 (USD Million)
7.6 Others
7.6.1 Others Market, 2017 – 2028 (USD Million)
Chapter 8 End-use Business Analysis
8.1 miRNA Sequencing And Assay Market: End-use Movement Analysis, 2020 & 2028
8.2 Pharmaceutical & Biotechnology Industry
8.2.1 Pharmaceutical & Biotechnology Industry Market, 2017 – 2028 (USD Million)
8.3 Research and Academic Institutes
8.3.1 Research and Academic Institutes Market, 2017 – 2028 (USD Million)
8.4 Contract Research Organizations
8.4.1 Contract Research Organizations Market, 2017 – 2028 (USD Million)
Chapter 9 Regional Business Analysis
9.1 MiRNA Sequencing & Assay Market Share By Region, 2020 & 2028
9.2 North America
9.2.1 North America MiRNA sequencing & assay market estimates and forecast, 2017 – 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.2.2.2 U.S. miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.2.2.3 U.S. miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.2.2.4 U.S. miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.2.2.5 U.S. miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.2.3.2 Canada miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.2.3.3 Canada miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.2.3.4 Canada miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.2.3.5 Canada miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.3 Europe
9.3.1 Europe MiRNA sequencing & assay market estimates and forecast, 2017 – 2028 (USD Million)
9.3.2 U.K.
9.3.2.1 U.K. miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.3.2.2 U.K. miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.3.2.3 U.K. miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.3.2.4 U.K. miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.3.2.5 U.K. miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.3.3 Germany
9.3.3.1 Germany miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.3.3.2 Germany miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.3.3.3 Germany miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.3.3.4 Germany miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.3.3.5 Germany miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.3.4 France
9.3.4.1 France miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.3.4.2 France miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.3.4.3 France miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.3.4.4 France miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.3.4.5 France miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.3.5 Italy
9.3.5.1 Italy miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.3.5.2 Italy miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.3.5.3 Italy miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.3.5.4 Italy miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.3.5.5 Italy miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.3.6.2 Spain miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.3.6.3 Spain miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.3.6.4 Spain miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.3.6.5 Spain miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific MiRNA sequencing & assay market estimates and forecast, 2017 – 2028 (USD Million)
9.4.2 China
9.4.2.1 China miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.4.2.2 China miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.4.2.3 China miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.4.2.4 China miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.4.2.5 China miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.4.3 Japan
9.4.3.1 Japan miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.4.3.2 Japan miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.4.3.3 Japan miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.4.3.4 Japan miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.4.3.5 Japan miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.4.4 India
9.4.4.1 India miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.4.4.2 India miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.4.4.3 India miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.4.4.4 India miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.4.4.5 India miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.4.5 Australia
9.4.5.1 Australia miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.4.5.2 Australia miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.4.5.3 Australia miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.4.5.4 Australia miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.4.5.5 Australia miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.4.6.2 South Korea miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.4.6.3 South Korea miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.4.6.4 South Korea miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.4.6.5 South Korea miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America MiRNA sequencing & assay market estimates and forecast, 2017 – 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.5.2.2 Brazil miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.5.2.3 Brazil miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.5.2.4 Brazil miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.5.2.5 Brazil miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.5.3.2 Mexico miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.5.3.3 Mexico miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.5.3.4 Mexico miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.5.3.5 Mexico miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.6 MEA
9.6.1 MEA MiRNA sequencing & assay market estimates and forecast, 2017 – 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.6.2.2 South Africa miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.6.2.3 South Africa miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.6.2.4 South Africa miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.6.2.5 South Africa miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia miRNA sequencing and assay market, by product & service, 2017 – 2028 (USD Million)
9.6.3.2 Saudi Arabia miRNA sequencing and assay market, by technology, 2017 – 2028 (USD Million)
9.6.3.3 Saudi Arabia miRNA sequencing and assay market, by workflow, 2017 – 2028 (USD Million)
9.6.3.4 Saudi Arabia miRNA sequencing and assay market, by application, 2017 – 2028 (USD Million)
9.6.3.5 Saudi Arabia miRNA sequencing and assay market, by end use, 2017 – 2028 (USD Million)
Chapter 10 COMPETITIVE LANDSCAPE
10.1 Company categorization
10.2 Strategy framework
10.2.1 Thermo Fisher Scientific, Inc.
10.2.1.1 Company overview
10.2.1.2 Financial performance
10.2.1.3 Product benchmarking
10.2.1.4 Strategic initiatives
10.2.2 Illumina, Inc.
10.2.2.1 Company overview
10.2.2.2 Financial Performance
10.2.2.3 Product benchmarking
10.2.3 QIAGEN
10.2.3.1 Company overview
10.2.3.2 Financial Performance
10.2.3.3 Product benchmarking
10.2.4 PerkinElmer, Inc.
10.2.4.1 Company overview
10.2.4.2 Financial Performance
10.2.4.3 Product benchmarking
10.2.5 Abcam plc
10.2.5.1 Company overview
10.2.5.2 Financial Performance
10.2.5.3 Product benchmarking
10.2.6 New England Biolabs
10.2.6.1 Company overview
10.2.6.2 Financial Performance
10.2.6.3 Product benchmarking
10.2.7 Takara Bio Inc.
10.2.7.1 Company overview
10.2.7.2 Financial Performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 Lexogen GmbH
10.2.8.1 Company overview
10.2.8.2 Financial Performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 Norgen Biotek Corp.
10.2.9.1 Company overview
10.2.9.2 Financial Performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives
10.2.10 Maravai LifeSciences
10.2.10.1 Company overview
10.2.10.1.1 TriLink BioTechnologies
10.2.10.2 Financial Performance
10.2.10.3 Product benchmarking
10.2.10.4 Strategic initiatives
10.2.11 HTG Molecular Diagnostics, Inc.
10.2.11.1 Company overview
10.2.11.2 Financial performance
10.2.11.3 Product benchmarking
10.2.11.4 Strategic initiatives
10.2.12 Meridian Bioscience, Inc.
10.2.12.1 Company overview
10.2.12.2 Financial performance
10.2.12.3 Product benchmarking
10.2.12.4 Strategic initiatives
10.2.13 System Biosciences, LLC.
10.2.13.1 Company overview
10.2.13.2 Financial Performance
10.2.13.3 Product benchmarking

List of Tables

Table 1 Oxford Nanopore Technologies Product Comparison
Table 2 Comparison of Sanger Sequencing and NGS
Table 3 Illumina, Inc. Data Analysis & Storage Informatics Products offering
Table 4 MicroRNAs in Autoimmune Diseases
Table 5 U.S. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 6 U.S. miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 7 U.S. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 8 U.S. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 9 U.S. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 10 U.S. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 11 Canada miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 12 Canada miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 13 Canada miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 14 Canada miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 15 Canada miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 16 Canada miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 17 U.K. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 18 U.K. miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 19 U.K. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 20 U.K. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 21 U.K. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 22 U.K. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 23 Germany miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 24 Germany miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 25 Germany miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 26 Germany miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 27 Germany miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 28 Germany miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 29 France miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 30 France miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 31 France miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 32 France miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 33 France miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 34 France miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 35 Italy miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 36 Italy miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 37 Italy miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 38 Italy miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 39 Italy miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 40 Italy miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 41 Spain miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 42 Spain miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 43 Spain miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 44 Spain miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 45 Spain miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 46 Spain miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 48 China miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 49 China miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 50 China miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 51 China miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 52 China miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 53 China miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 54 Japan miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 55 Japan miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 56 Japan miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 57 Japan miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 58 Japan miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 59 Japan miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 60 India miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 61 India miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 62 India miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 63 India miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 64 India miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 65 India miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 66 Australia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 67 Australia miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 68 Australia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 69 Australia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 70 Australia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 71 Australia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 72 South Korea miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 73 South Korea miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 74 South Korea miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 75 South Korea miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 76 South Korea miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 77 South Korea miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 78 Brazil miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 79 Brazil miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 80 Brazil miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 81 Brazil miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 82 Brazil miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 83 Brazil miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 84 Mexico miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 85 Mexico miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 86 Mexico miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 87 Mexico miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 88 Mexico miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 89 Mexico miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 91 South Africa miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 92 South Africa miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 93 South Africa miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 94 South Africa miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 95 South Africa miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 96 South Africa miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 97 Saudi Arabia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 98 Saudi Arabia miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 99 Saudi Arabia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 100 Saudi Arabia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 101 Saudi Arabia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 102 Saudi Arabia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot, 2020, (USD Million)
Fig. 9 Generations of sequencing
Fig. 10 Market segmentation & scope
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Advantages of miRNA sequencing
Fig. 14 Market restraint analysis
Fig. 15 Market opportunity analysis
Fig. 16 Market challenge analysis
Fig. 17 Penetration & growth prospect mapping for technology, 2020
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 Porter’s Five Forces Analysis
Fig. 20 miRNA sequencing and assay market: Product & Services outlook key takeaways
Fig. 21 miRNA sequencing and assay market: Product & Services movement analysis
Fig. 22 MiRNA Sequencing and Assay Products Market, 2017 - 2028 (USD Million)
Fig. 23 Library Preparation Kits Market, 2017 - 2028 (USD Million)
Fig. 24 Sequencing Consumables Market, 2017 - 2028 (USD Million)
Fig. 25 Instruments market, 2017 - 2028 (USD Million)
Fig. 26 MiRNA Sequencing and Assay Services Market, 2017 - 2028 (USD Million)
Fig. 27 miRNA sequencing and assay market: Technology outlook key takeaways
Fig. 28 miRNA sequencing and assay market: Technology movement analysis
Fig. 29 Thermo Fisher Scientific - Small RNA sequencing workflow for Ion Torrent next-generation sequencing systems
Fig. 30 Sequencing by Synthesis Market, 2017 - 2028 (USD Million)
Fig. 31 Sequencing by Oligonucleotide Ligation and Detection (SOLiD) Market, 2017 - 2028 (USD Million)
Fig. 32 Nanopore Sequencing Market, 2017 - 2028 (USD Million)
Fig. 33 Sanger Sequencing Market, 2017 - 2028 (USD Million)
Fig. 34 Single Molecule Real-time (SMRT) Sequencing Market, 2017 - 2028 (USD Million)
Fig. 35 miRNA sequencing and assay market: Workflow outlook key takeaways
Fig. 36 miRNA sequencing and assay market: Workflow movement analysis
Fig. 37 Library preparation workflow market, 2017 - 2028 (USD Million)
Fig. 38 Sequencing Workflow Market, 2017 - 2028 (USD Million)
Fig. 39 Data Analysis & Storage Workflow Market, 2017 - 2028 (USD Million)
Fig. 40 miRNA sequencing and assay market: Applications outlook key takeaways
Fig. 41 miRNA sequencing and assay market: Applications movement analysis
Fig. 42 Cancer Market, 2017 - 2028 (USD Million)
Fig. 43 Polyglutamine Diseases Market, 2017 - 2028 (USD Million)
Fig. 44 Autoimmune Disease Market, 2017 - 2028 (USD Million)
Fig. 45 Schizophrenia Market, 2017 - 2028 (USD Million)
Fig. 46 Others Market, 2017 - 2028 (USD Million)
Fig. 47 miRNA sequencing and assay market: End-use outlook key takeaways
Fig. 48 miRNA sequencing and assay market: End-use movement analysis
Fig. 49 Pharmaceutical & Biotechnology Industry Market, 2017 - 2028 (USD Million)
Fig. 50 Research and Academic Institutes Market, 2017 - 2028 (USD Million)
Fig. 51 Contract Research Organizations Market, 2017 - 2028 (USD Million)
Fig. 52 Regional marketplace: Key takeaway
Fig. 53 MiRNA sequencing & assay market: Regional movement analysis
Fig. 54 North America
Fig. 55 North America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 56 U.S.
Fig. 57 Canada
Fig. 58 Europe
Fig. 59 Europe MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 60 U.K.
Fig. 61 Germany
Fig. 62 France
Fig. 63 Italy
Fig. 64 Spain
Fig. 65 Asia Pacific
Fig. 66 Asia Pacific MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 China
Fig. 68 Japan
Fig. 69 India
Fig. 70 Australia
Fig. 71 South Korea
Fig. 72 Latin America
Fig. 73 Latin America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 74 Brazil
Fig. 75 Mexico
Fig. 76 MEA
Fig. 77 MEA MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 78 South Africa
Fig. 79 Saudi Arabia
Fig. 80 Company categorization
Fig. 81 Strategy framework

★調査レポート[世界のmiRNAシーケンス・アッセイ市場2021-2028：製品・サービス別、技術別、ワークフロー別、用途別（がん、自己免疫疾患、統合失調症）、エンドユーザー別、地域別] (コード：GV21JL022)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のmiRNAシーケンス・アッセイ市場2021-2028：製品・サービス別、技術別、ワークフロー別、用途別（がん、自己免疫疾患、統合失調症）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 腫瘍治療におけるNGSのインド市場2021-2028：最終用途別（臨床研究、病院＆クリニック）、技術別、用途別、製品＆サービス別、ワークフロー別
    GV21DC074 / Grand View Research / 2021年12月13日 / グランドビューリサーチ社は、腫瘍治療におけるNGSのインド市場規模が年平均19.6％成長し、2028年までに70.60百万ドルに達すると予測しています。本調査レポートは、インドの腫瘍治療におけるNGS市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、技術別分析、用途別分析、製品＆サービス別分析、ワークフロー別分析、最終用途別分析、企業情報などの項目を掲載しています。...
  • 世界のメタゲノムシーケンス市場2022-2028：製品・サービス別（試薬＆消耗品、機器、サービス、分析＆データ解釈ソリューション）、ワークフロー別、技術別、用途別、地域別
    BZW22AP176 / Bizwit Research & Consulting / 2022年3月16日 / Bizwit Research社は、2021年におよそ11.7億ドルであった世界のメタゲノムシーケンス市場規模が、2022年から2028年の間に17.0％以上成長すると予測しています。本調査資料では、メタゲノムシーケンスの世界市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品・サービス別（試薬＆消耗品、機器、サービス、分析＆データ解釈ソリューション）分析、ワークフロー別（サンプル処理＆ライブラリ調製、シーケンス、データ処理＆分析）分析、技術別（ショットガンメタゲノムシーケンス、16S rRNAシーケンス、メタトランスクリプトミクス、全ゲノムシーケンス＆DeNovoアセンブリ）分析、用途別（薬物発見、臨床診断、土壌マイクロバイオーム、生態・環境、獣医）分析、地域別分析、競争分析、調査プロセスなど、以下の項目を掲載しています。 ・エグゼクティブサマリー ・市場定義・範囲...
  • 世界のメタゲノムシーケンシング市場2022-2028：製品・サービス別（試薬・消耗品、機器、サービス、分析・データ解析ソリューション）、ワークフロー別、技術別、用途別、地域別
    BZW22JL040 / Bizwit Research & Consulting / 2022年5月9日 / Bizwit Research社は、2021年におよそ16億ドルであった世界のメタゲノムシーケンシング市場規模が、2022年から2028年の間に18%以上成長すると予測しています。本調査レポートでは、メタゲノムシーケンシングの世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品・サービス別（試薬・消耗品、機器、サービス、分析・データ解析ソリューション）分析、ワークフロー別（サンプル処理・ライブラリー作成、シーケンス、データ処理・解析）分析、技術別（ショットガンメタゲノムシーケンス、16S rRNAシーケンス、エタトランススクリプトミクス、全ゲノムシーケンス・De Novo アセンブリ）分析、用途別（創薬、臨床診断、土壌微生物叢の用途、産業用途、その他）分析、地域別分析、競争分析、調査プロセスなどを掲載しています。...
  • 世界の空間OMICS市場2021-2028：技術別（トランスクリプトミクス、ゲノミクス、プロテオミクス）、製品別、ワークフロー別、サンプル種類別、エンドユーザー別、地域別
    GV21JL012 / Grand View Research / 2021年7月6日 / グランドビューリサーチ社は、空間OMICSの世界市場規模が2028年までに484.22百万ドルに達すると予測しています。2021年から2028年まで年平均10％成長する見通しです。本市場調査レポートでは、空間OMICの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、産業動向、技術別（空間プロテオミクス、空間トランスクリプトミクス、空間ゲノミクス）分析、製品別（機器、消耗品、ソフトウェア）分析、ワークフロー別（サンプルプレパレーション、機器分析、データ分析）分析、サンプル種類別（FFPE、新鮮凍結）分析、地域別分析、競争状況などの項目を掲載しています。 ・調査手法・範囲 ・エグゼクティブサマリー ・産業動向 ・空間OMICの世界市場規模：技術別（空間プロテオミクス、空間トランスクリプトミクス、空間ゲノミクス）...
  • 世界の使い捨てバイオプロセシングプローブ・センサー市場2021-2028：センサータイプ別（pHセンサー、酸素センサー）、ワークフロー別（アップストリーム、ダウンストリーム）、エンドユーザー別、地域別
    GV21AU109 / Grand View Research / 2021年7月23日 / グランドビューリサーチ社は、使い捨てバイオプロセシングプローブ・センサーの世界市場規模が2028年までに54億ドルに達し、2021年から2028年までに年平均13.9%成長すると予測しています。本市場調査レポートは、世界の使い捨てバイオプロセシングプローブ・センサー市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争状況、センサータイプ別（pHセンサー、酸素センサー、圧力センサー、温度センサー、導電率センサー、その他）分析、ワークフロー別（アップストリーム、ダウンストリーム）分析、エンドユーザー別（CMOS・CROS、バイオメーカー、研究所・学術・臨床研究機関）分析、地域別分析、企業情報などを掲載しています。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場変動・動向・範囲 ・競争状況...

    • ◆H&Iグローバルリサーチのお客様（例）◆